Status:
UNKNOWN
Ion Irradiation of Sacrococcygeal Chordoma
Lead Sponsor:
Heidelberg University
Conditions:
Sacral Chordoma
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety and feasibility of primary hypofractionated irradiation of sacrococcygeal chordoma with carbon ions or protons using the raster scan technique.
Detailed Description
The primary objective of this trial is safety and feasibility of hypofractionated irradiation in patients with sacrococcygeal chordoma using protons or carbon ions in raster scan technique for primary...
Eligibility Criteria
Inclusion
- Histological confirmation of sacrococcygeal chordoma
- Karnofsky performance status ≥ 70%
- Patients age 18 - 80 years
- Macroscopic tumour (MRI)
- Written informed consent
Exclusion
- Lack of macroscopic tumour
- Tumor extension in craniocaudal direction \>16cm
- Metal implants at the level of the tumor which could influence the treatment planning
- Inability of the patient to lie quiet for at least 20 minutes (eg due to pain)
- Prior radiotherapy of the pelvic region
- Simultaneous participation in another trial that could influence the results of the study
- Active medical implants without treatment approval at the time of ion irradiation (eg, cardiac pacemaker, defibrillator)
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01811394
Start Date
January 1 2013
End Date
June 1 2025
Last Update
December 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Heidelberg, Radiooncology, HIT
Heidelberg, Germany, 69125